145 related articles for article (PubMed ID: 11825409)
21. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
22. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
[TBL] [Abstract][Full Text] [Related]
23. Liver function improvement following increased portal blood flow in cirrhotic rats.
Cardoso JE; Giroux L; Kassissia I; Houssin D; Habib N; Huet PM
Gastroenterology; 1994 Aug; 107(2):460-7. PubMed ID: 8039623
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation.
Smyrniotis V; Kostopanagiotou G; Kondi A; Gamaletsos E; Theodoraki K; Kehagias D; Mystakidou K; Contis J
Transpl Int; 2002 Jul; 15(7):355-60. PubMed ID: 12122512
[TBL] [Abstract][Full Text] [Related]
25. On the pathogenesis of portal hypertension in cirrhosis of the liver.
Shibayama Y
Liver; 1988 Apr; 8(2):95-9. PubMed ID: 3367713
[TBL] [Abstract][Full Text] [Related]
26. Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.
Shibamoto T; Kamikado C; Koyama S
Pflugers Arch; 2008 Jun; 456(3):467-77. PubMed ID: 18193271
[TBL] [Abstract][Full Text] [Related]
27. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
28. Localization of increased hepatic vascular resistance in liver cirrhosis.
Shibayama Y; Nakata K
Hepatology; 1985; 5(4):643-8. PubMed ID: 4018737
[TBL] [Abstract][Full Text] [Related]
29. [Adrenoceptors in the hepatic tissues in cirrhotic rats and cirrhotic patients with portal hypertension].
Feng H; Leng X; Zhang Z
Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):175-7. PubMed ID: 9596953
[TBL] [Abstract][Full Text] [Related]
30. [Correlative study between portal vein pressure and portal hemodynamics in patients with portal hypertension].
Liu Y; Li L; Yu Z; Liu Q; Li Z; Wang Y; Zhang Q
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):135-7. PubMed ID: 11983136
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
[TBL] [Abstract][Full Text] [Related]
32. Endothelin-induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats.
Elliot AJ; Vo LT; Grossman VL; Bhathal PS; Grossman HJ
J Gastroenterol Hepatol; 1997 Apr; 12(4):314-8. PubMed ID: 9195372
[TBL] [Abstract][Full Text] [Related]
33. Effects of carbon dioxide pneumoperitoneum on hemodynamics in cirrhotic rats.
Tsuboi S; Kitano S; Yoshida T; Bandoh T; Ninomiya K; Baatar D
Surg Endosc; 2002 Aug; 16(8):1220-5. PubMed ID: 11984669
[TBL] [Abstract][Full Text] [Related]
34. [Nitric oxide in pathogenesis of cirrhotic portal hypertension in rats and its hemodynamic effects].
Zhang J; Zhou H
Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):317-9. PubMed ID: 11825400
[TBL] [Abstract][Full Text] [Related]
35. Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
Cerini F; Vilaseca M; Lafoz E; García-Irigoyen O; García-Calderó H; Tripathi DM; Avila M; Reverter JC; Bosch J; Gracia-Sancho J; García-Pagán JC
J Hepatol; 2016 Apr; 64(4):834-42. PubMed ID: 26686269
[TBL] [Abstract][Full Text] [Related]
36. Calcium receptors located in fibrotic septa: a new target to reduce portal pressure in liver cirrhosis.
Sansoè G; Aragno M; Mastrocola R; Paternostro C; Parola M
Clin Sci (Lond); 2013 Jul; 125(2):67-75. PubMed ID: 23384153
[TBL] [Abstract][Full Text] [Related]
37. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
[TBL] [Abstract][Full Text] [Related]
38. Systemic and regional changes in plasma endothelin following transient increase in portal pressure.
Kapoor D; Redhead DN; Hayes PC; Webb DJ; Jalan R
Liver Transpl; 2003 Jan; 9(1):32-9. PubMed ID: 12514771
[TBL] [Abstract][Full Text] [Related]
39. Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat.
Barrowman JA; Granger DN
Gastroenterology; 1984 Jul; 87(1):165-72. PubMed ID: 6724260
[TBL] [Abstract][Full Text] [Related]
40. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.
Matei V; Rodríguez-Vilarrupla A; Deulofeu R; Colomer D; Fernández M; Bosch J; Garcia-Pagán JC
Hepatology; 2006 Jul; 44(1):44-52. PubMed ID: 16799985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
